A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

NCT00891293 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Antara (fenofibrate) + Lovaza (omega-3-acid ethyl esters)

Sponsor

GlaxoSmithKline